Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Barclays (BARC) by Christopher Ruane in The Motley Fool
- Buy easyJet (EZJ) by Tom Winnifrith in ShareProphets
- Buy easyJet (EZJ) by Steve Moore in ShareProphets
- Avoid Tekmar Group (TGP) by Steve Moore in ShareProphets
- Buy Tristel (TSTL) by Mark Rogers in The Motley Fool
- Sell Mind Gym (MIND) by Steve Moore in ShareProphets
- Neutral Rio Tinto (RIO) by UBS
- Buy Baltic Classifieds Group (BCG) by Berenberg
- Underperform Whitbread (WTB) by Bernstein
- Buy Rolls-Royce Holdings (RR.) by Bank of America
- Buy Melrose Industries (MRO) by Bank of America
- Buy BAE Systems (BA.) by Bank of America
- Buy Babcock International Group (BAB) by Bank of America
- Buy Sirius Real Estate Ltd. (SRE) by Deutsche Bank
- Buy Helical (HLCL) by Deutsche Bank
- Buy Balfour Beatty (BBY) by Deutsche Bank
- Buy Discoverie Group (DSCV) by Deutsche Bank
- Hold Derwent London (DLN) by Deutsche Bank
- Buy Workspace Group (WKP) by Deutsche Bank
- Buy AJ Bell (AJB) by Deutsche Bank
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,420 open tips for GSK (GSK)
| Latest Bid : 1,797.50p | Latest Ask : 1,798.50p |
| High Today : 1,833.50p | Low Today : 1,796.00p |
| This Years High : 1,833.50p | This Years Low : 1,264.00p |
| Volume : 2,245,745 | MKT Cap : £74547.83M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Berenberg | Premium Only | 2025-11-25 05:38:00 25/11/2025 | 0.45% |
| Buy | Simon Watkins | Premium Only | 2025-11-10 10:00:00 10/11/2025 | 1.04% |
| Underweight | JP Morgan | Premium Only | 2025-11-07 04:48:00 07/11/2025 | -0.28% |
| Hold | Deutsche Bank | Premium Only | 2025-11-04 07:06:00 04/11/2025 | 1.84% |
| Neutral | UBS | Premium Only | 2025-10-31 09:01:00 31/10/2025 | – |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1,797.50p | Latest Ask : 1,798.50p |
| High Today : 1,833.50p | Low Today : 1,796.00p |
| This Years High : 1,833.50p | This Years Low : 1,264.00p |
| Volume : 2,245,745 | MKT Cap : £74547.83M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Berenberg | Premium Only | 2025-11-25 05:38:00 25/11/2025 | 0.45% |
| Buy | Simon Watkins | Premium Only | 2025-11-10 10:00:00 10/11/2025 | 1.04% |
| Underweight | JP Morgan | Premium Only | 2025-11-07 04:48:00 07/11/2025 | -0.28% |
| Hold | Deutsche Bank | Premium Only | 2025-11-04 07:06:00 04/11/2025 | 1.84% |
| Neutral | UBS | Premium Only | 2025-10-31 09:01:00 31/10/2025 | – |